Gray and white matter degeneration revealed by diffusion in an Alzheimer mouse model

Neurobiology of Aging

Volumn 34, Issue 5, 2013, Pages 1440-1450

  Zerbi, Valerio ^a,b   Kleinnijenhuis, Michiel ^a,c   Fang, Xiaotian ^a   Jansen, Diane ^a   Veltien, Andor ^b   Van Asten, Jack ^b   Timmer, Nienke ^a   Dederen, Pieter J ^a   Kiliaan, Amanda J ^a   Heerschap, Arend ^b  

^a RADBOUD UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Alzheimer's disease; APP PS1; Diffusion tensor imaging; Diffusivity; Mice; MRI; White matter

Indexed keywords

ALZHEIMER DISEASE; ANATOMICAL VARIATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DEGENERATION; CELL LOSS; CONTROLLED STUDY; CORPUS CALLOSUM; DIFFUSION TENSOR IMAGING; GENETIC VARIABILITY; GRAY MATTER; HIPPOCAMPAL FIMBRIA; HISTOPATHOLOGY; MALE; MOUSE; NERVE TRACT; NEUROANATOMY; NEUROIMAGING; NON INVASIVE PROCEDURE; NONHUMAN; PRIORITY JOURNAL; TRACTOGRAPHY; WHITE MATTER;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; HUMANS; MICE; MICE, TRANSGENIC; NERVE FIBERS, MYELINATED; NEURONS;

EID: 84873440065     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2012.11.017     Document Type: Article

References (58)

1. Arnold S.E., Hyman B.T., Flory J., Damasio A.R., Van Hoesen G.W. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1991, 1:103-116.
2. Avants B., Duda J.T., Kim J., Zhang H., Pluta J., Gee J.C., Whyte J. Multivariate analysis of structural and diffusion imaging in traumatic brain injury. Acad Radiol. 2008, 15(11):1360-1375.
3. Basser P.J., Mattiello J., LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys. J. 1994, 66:259-267.
4. Beaulieu C. The basis of anisotropic water diffusion in the nervous system - a technical review. NMR Biomed. 2002, 15:435-455.
5. Bodian David. A new method for staining nerve fibers and nerve endings in mounted paraffin sections. Anat. Rec. 1936, 65:89-97.
6. Bodian David. The staining of paraffin sections of nervous tissues with activated protargol. The role of fixatives Anat. Rec. 1937, 69:153-162.
7. Bozzali M., Falini A., Franceschi M., Cercignani M., Zuffi M., Scotti G., Comi G., Filippi M. White matter damage in Alzheimer's disease assessed in vivo using diffusion tensor magnetic resonance imaging. J. Neurol. Neurosurg. Psychiatry 2002, 72:742-746.
8. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
9. Braak H., Braak E. Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 1995, 16:271-278. discussion 278-284.
10. Bronge L., Bogdanovic N., Wahlund L.O. Postmortem MRI and histopathology of white matter changes in Alzheimer brains. A quantitative, comparative study. Dement. Geriatr. Cogn. Disord. 2002, 13:205-212.
11. Budde M.D., Frank J.A. Examining brain microstructure using structure tensor analysis of histological sections. Neuroimage 2012, 63:1-10.
12. Carlesimo G.A., Cherubini A., Caltagirone C., Spalletta G. Hippocampal mean diffusivity and memory in healthy elderly individuals: a cross-sectional study. Neurology 2010, 74:194-200.
13. Chen H., Epelbaum S., Delatour B. Fiber tracts anomalies in APPxPS1 transgenic mice modeling Alzheimer's disease. J. Aging Res. 2011, 2011:281274.
14. de Groot J.C., de Leeuw F.E., Oudkerk M., van Gijn J., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann. Neurol. 2000, 47:145-151.
15. de la Torre J.C. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002, 33:1152-1162.
16. Delatour B., Guegan M., Volk A., Dhenain M. In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice. Neurobiol. Aging 2006, 27:835-847.
17. Di Paola M., Di Iulio F., Cherubini A., Blundo C., Casini A.R., Sancesario G., Passafiume D., Caltagirone C., Spalletta G. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study. Neurology 2010, 74:1136-1142.
18. Douaud G., Jbabdi S., Behrens T.E., Menke R.A., Gass A., Monsch A.U., Rao A., Whitcher B., Kindlmann G., Matthews P.M., Smith S. DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage 2011, 55:880-890.
19. Dubois A., Herard A.S., Delatour B., Hantraye P., Bonvento G., Dhenain M., Delzescaux T. Detection by voxel-wise statistical analysis of significant changes in regional cerebral glucose uptake in an APP/PS1 transgenic mouse model of Alzheimer's disease. Neuroimage 2010, 51:586-598.
20. Dubois A., Herard A.S., Flandin G., Duchesnay E., Besret L., Frouin V., Hantraye P., Bonvento G., Delzescaux T. Quantitative validation of voxel-wise statistical analyses of autoradiographic rat brain volumes: application to unilateral visual stimulation. Neuroimage 2008, 40:482-494.
21. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement. Geriatr. Cogn. Disord. 1998, 9(suppl 1):6-12.
22. Englund E., Brun A. White matter changes in dementia of Alzheimer's type: the difference in vulnerability between cell compartments. Histopathology 1990, 16:433-439.
23. Fellgiebel A., Wille P., Muller M.J., Winterer G., Scheurich A., Vucurevic G., Schmidt L.G., Stoeter P. Ultrastructural hippocampal and white matter alterations in mild cognitive impairment: a diffusion tensor imaging study. Dement. Geriatr. Cogn. Disord. 2004, 18:101-108.
24. Fellgiebel A., Dellani P.R., Greverus D., Scheurich A., Stoeter P., Muller M.J. Predicting conversion to dementia in mild cognitive impairment by volumetric and diffusivity measurements of the hippocampus. Psychiatry Res. 2006, 146:283-287.
25. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego.
26. Garcia-Alloza M., Robbins E.M., Zhang-Nunes S.X., Purcell S.M., Betensky R.A., Raju S., Prada C., Greenberg S.M., Bacskai B.J., Frosch M.P. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 2006, 24:516-524.
27. Hanyu H., Sakurai H., Iwamoto T., Takasaki M., Shindo H., Abe K. Diffusion-weighted MR imaging of the hippocampus and temporal white matter in Alzheimer's disease. J. Neurol. Sci. 1998, 156:195-200.
28. Harms M.P., Kotyk J.J., Merchant K.M. Evaluation of white matter integrity in ex vivo brains of amyloid plaque-bearing APPsw transgenic mice using magnetic resonance diffusion tensor imaging. Exp. Neurol. 2006, 199:408-415.
29. Harsan L.A., Paul D., Schnell S., Kreher B.W., Hennig J., Staiger J.F., von Elverfeldt D. In vivo diffusion tensor magnetic resonance imaging and fiber tracking of the mouse brain. NMR Biomed. 2010, 23:884-896.
30. Hooijmans C.R., Van der Zee C.E., Dederen P.J., Brouwer K.M., Reijmer Y.D., van Groen T., Broersen L.M., Lutjohann D., Heerschap A., Kiliaan A.J. DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe/PS1dE9 mice. Neurobiol. Dis. 2009, 33:482-498.
31. Jankowsky J.L., Slunt H.H., Ratovitski T., Jenkins N.A., Copeland N.G., Borchelt D.R. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 2001, 17:157-165.
32. Jankowsky J.L., Slunt H.H., Gonzales V., Jenkins N.A., Copeland N.G., Borchelt D.R. APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1. Neurobiol. Aging 2004, 25:885-892.
33. Jiang Y., Johnson G.A. Microscopic diffusion tensor imaging of the mouse brain. Neuroimage 2010, 50:465-471.
34. Kantarci K. Diffusion tensor imaging in Alzheimer's disease. Curr. Med. Imaging Rev. 2011, 7:6.
35. Kantarci K., Petersen R.C., Boeve B.F., Knopman D.S., Weigand S.D., O'Brien P.C., Shiung M.M., Smith G.E., Ivnik R.J., Tangalos E.G., Jack C.R. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2005, 64:902-904.
36. Klüver H., Barrera E. A method for the combined staining of cells and fibers in the Nervous system. J. Nueropath. Exp. Neurol. 1953, 12:400-403.
37. Kwong K.K., McKinstry R.C., Chien D., Crawley A.P., Pearlman J.D., Rosen B.R. CSF-suppressed quantitative single-shot diffusion imaging. Magn. Reson. Med. 1991, 21:157-163.
38. Le Bihan D., Breton E., Lallemand D., Grenier P., Cabanis E., Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986, 161:401-407.
39. Liu Y., Yoo M.J., Savonenko A., Stirling W., Price D.L., Borchelt D.R., Mamounas L., Lyons W.E., Blue M.E., Lee M.K. Amyloid pathology is associated with progressive monoaminergic neurodegeneration in a transgenic mouse model of Alzheimer's disease. J Neurosci 2008, 17;28(51):13805-13814. http://dx.doi.org/10.1523/JNEUROSCI.4218-08.2008.
40. Malm T., Koistinaho J., Kanninen K. Utilization of APPswe/PS1dE9 transgenic mice in research of Alzheimer's disease: focus on gene therapy and cell-based therapy applications. Int. J. Alzheimers Dis. 2011, 2011:517160.
41. Medina D., DeToledo-Morrell L., Urresta F., Gabrieli J.D., Moseley M., Fleischman D., Bennett D.A., Leurgans S., Turner D.A., Stebbins G.T. White matter changes in mild cognitive impairment and AD: a diffusion tensor imaging study. Neurobiol. Aging 2006, 27:663-672.
42. Mueggler T., Meyer-Luehmann M., Rausch M., Staufenbiel M., Jucker M., Rudin M. Restricted diffusion in the brain of transgenic mice with cerebral amyloidosis. Eur. J. Neurosci. 2004, 20:811-817.
43. Ramos B., Baglietto-Vargas D., del Rio J.C., Moreno-Gonzalez I., Santa-Maria C., Jimenez S., Caballero C., Lopez-Tellez J.F., Khan Z.U., Ruano D., Gutierrez A., Vitorica J. Early neuropathology of somatostatin/NPY GABAergic cells in the hippocampus of a PS1xAPP transgenic model of Alzheimer's disease. Neurobiol. Aging 2006, 27:1658-1672.
44. Ruest T., Holmes W.M., Barrie J.A., Griffiths I.R., Anderson T.J., Dewar D., Edgar J.M. High-resolution diffusion tensor imaging of fixed brain in a mouse model of Oelizaeus-Merzbacher disease: comparison with quantative measores of white matter pathology. NMR Biomed. 2011, 24:1369-1379.
45. Sawiak S.J., Wood N.I., Williams G.B., Morton A.J., Carpenter T.A. Voxel-based morphometry in the R6/2 transgenic mouse reveals differences between genotypes not seen with manual 2D morphometry. Neurobiol. Dis. 2009, 33:20-27.
46. Schmitz C., Rutten B.P., Pielen A., Schafer S., Wirths O., Tremp G., Czech C., Blanchard V., Multhaup G., Rezaie P., Korr H., Steinbusch H.W., Pradier L., Bayer T.A. Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 2004, 164:1495-1502.
47. Song S.K., Kim J.H., Lin S.J., Brendza R.P., Holtzman D.M. Diffusion tensor imaging detects age-dependent white matter changes in a transgenic mouse model with amyloid deposition. Neurobiol. Dis. 2004, 15:640-647.
48. Song S.K., Yoshino J., Le T.Q., Lin S.J., Sun S.W., Cross A.H., Armstrong R.C. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage 2005, 26:132-140.
49. Sun S.W., Liang H.F., Cross A.H., Song S.K. Evolving Wallerian degeneration after transient retinal ischemia in mice characterized by diffusion tensor imaging. Neuroimage 2008, 40:1-10.
50. Sun S.W., Song S.K., Harms M.P., Lin S.J., Holtzman D.M., Merchant K.M., Kotyk J.J. Detection of age-dependent brain injury in a mouse model of brain amyloidosis associated with Alzheimer's disease using magnetic resonance diffusion tensor imaging. Exp. Neurol. 2005, 191:77-85.
51. Sykova E., Vorisek I., Antonova T., Mazel T., Meyer-Luehmann M., Jucker M., Hajek M., Ort M., Bures J. Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:479-484.
52. Teipel S.J., Bayer W., Alexander G.E., Zebuhr Y., Teichberg D., Kulic L., Schapiro M.B., Moller H.J., Rapoport S.I., Hampel H. Progression of corpus callosum atrophy in Alzheimer disease. Arch. Neurol. 2002, 59:243-248.
53. Tomimoto H., Lin J.X., Matsuo A., Ihara M., Ohtani R., Shibata M., Miki Y., Shibasaki H. Different mechanisms of corpus callosum atrophy in Alzheimer's disease and vascular dementia. J. Neurol. 2004, 251:398-406.
54. Tournier J.D., Calamante F., Connelly A. Robust determination of the fibre orientation distribution in diffusion MRI: non-negativity constrained super-resolved spherical deconvolution. Neuroimage 2007, 35:1459-1472.
55. Wu E.X., Tang H., Asai T., Yan S.D. Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice. Neurosci. Lett. 2004, 365:223-227.
56. Xie S., Xiao J.X., Gong G.L., Zang Y.F., Wang Y.H., Wu H.K., Jiang X.X. Voxel-based detection of white matter abnormalities in mild Alzheimer disease. Neurology 2006, 66:1845-1849.
57. Zerbi V., Jansen D., Dederen P.J., Veltien A., Hamans B., Liu Y., Heerschap A., Kiliaan A.J. Microvascular cerebral blood volume changes in aging APP(swe)/PS1 (dE9) AD mouse model: a voxel-wise approach. Brain Struct. Funct. 2012, http://dx.doi.org/10.1007/s00429-012-0448-8.
58. Zwiers M.P. Patching cardiac and head motion artefacts in diffusion-weighted images. Neuroimage 2010, 53:565-575.